PE firm CBC eyes more listings after Chinese firm I-Mab's debut in US

PE firm CBC eyes more listings after Chinese firm I-Mab's debut in US

Medical drugs in a pharmacy. Credit: Flickr/epSos .de

Manuel Baigorri

24 January, 2020

CBC Group I-Mab

Printed by Unregistered user on Sun, 27 Jul 2025 10:06:06 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese drug developer I-Mab Biopharma said to file for US IPO

China's Oceanwide sells San Francisco property project at loss

Read more from Greater China

Editor’s Take: The Week That Was—July 21-26

Hong Kong IPO boom triggers price war among banks